Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Meghali Thakre-Nighot & Anthony T. Blikslager. (2016) Indomethacin induces increase in gastric epithelial tight junction permeability via redistribution of occludin and activation of p38 MAPK in MKN-28 Cells. Tissue Barriers 4:3.
Read now
Read now
Roy Altman, Marc Hochberg, Allan Gibofsky, Mark Jaros & Clarence Young. (2015) Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study. Current Medical Research and Opinion 31:12, pages 2331-2343.
Read now
Read now
Articles from other publishers (9)
Nan Ding, Chao Chen, Yishu Liu, Peiyong Zheng, Xue Li & Ming Yang. (2024) Simultaneous determination of plasma protein binding of five C-glycosylflavones from TFDS by rapid equilibrium dialysis. Analytical Biochemistry 690, pages 115511.
Crossref
Crossref
Laura S. Graham, Lawrence D. True, Roman Gulati, George R. Schade, Jonathan Wright, Petros Grivas, Todd Yezefski, Katie Nega, Katerina Alexander, Wen‐Min Hou, Evan Y. Yu, Bruce Montgomery, Elahe A. Mostaghel, Alvin A. Matsumoto, Brett Marck, Nima Sharifi, William J. Ellis, Nicholas P. Reder, Daniel W. Lin, Peter S. Nelson & Michael T. Schweizer. (2021) Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high‐risk localized prostate cancer. The Prostate 81:7, pages 418-426.
Crossref
Crossref
Khaled R. A. Abdellatif, Eman K. A. Abdelall, Heba A. H. Elshemy, El‐Shaymaa El‐Nahass, Maha M. Abdel‐Fattah & Yasmin Y. M. Abdelgawad. (2020) New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studies. Archiv der Pharmazie 354:4.
Crossref
Crossref
Jibin Li, Li-Bin Li, Nourdine Nessah, Yuehua Huang, Carlos Hidalgo, Albert Owen & Ismael J. Hidalgo. (2019) Simultaneous Analysis of Dissolution and Permeation Profiles of Nanosized and Microsized Formulations of Indomethacin Using the In Vitro Dissolution Absorption System 2. Journal of Pharmaceutical Sciences 108:7, pages 2334-2340.
Crossref
Crossref
Raymond E. Lai, Christopher E. Jay & Douglas H. Sweet. (2018) Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs. Journal of Food and Drug Analysis 26:2, pages S45-S60.
Crossref
Crossref
Christopher G. Gharibo, Charles Argoff, Joseph A. Markenson, Lynn R. Webster, Jennifer Nezzer, Daniel Solorio, Melanie Lauterio & Clarence Young. (2018) Opioid-sparing Effects of SoluMatrix Indomethacin in a Phase 3 Study in Patients With Acute Postoperative Pain. The Clinical Journal of Pain 34:2, pages 138-144.
Crossref
Crossref
Jingjing Ma, Ying Gao, Yinghua Sun, Dawei Ding, Qi Zhang, Bingjun Sun, Menglin Wang, Jin Sun & Zhonggui He. (2017) Tissue distribution and dermal drug determination of indomethacin transdermal-absorption patches. Drug Delivery and Translational Research 7:5, pages 617-624.
Crossref
Crossref
T. Toimela, O. Huttala, E. Sabell, M. Mannerström, J.R. Sarkanen, T. Ylikomi & T. Heinonen. (2017) Intra-laboratory validated human cell-based in vitro vasculogenesis/angiogenesis test with serum-free medium. Reproductive Toxicology 70, pages 116-125.
Crossref
Crossref
Michiko Nakamura & Il-Sung Jang. (2016) Indomethacin inhibits tetrodotoxin-resistant Na+ channels at acidic pH in rat nociceptive neurons. Neuropharmacology 105, pages 454-462.
Crossref
Crossref